News
-
Australian pharma faces AI reality check
- Mon Sep 14
AI is boosting efficiency, but concerns are rising as people working in Aussie pharma start questioning its impact on long‑term job security.
Read more -
Pharmas rise in TIME’s Best Company ranks
- Mon Sep 14
Big pharmas placed well in TIME Magazine’s Top 100 Best Companies of 2026, one taking out a top five spot. Who failed to make the cut?
Read more -
Global CAR‑T trial for kids coming Downunder
- Mon Sep 14
Funding to join UK CAR‑T Pathfinder Trial and Paediatric Cell Therapy Accelerator, bringing international clinical trials to Australia.
Read more -
Doctors demand companies act on misinformation
- Fri Sep 11
EXCLUSIVE: Fed up with misinformed patients, Australian clinicians say pharma companies must correct the record or face prescriber backlash.
Read more -
PBAC harmony? That’s a matter of perspective
- Fri Sep 11
OP-ED: Broad funding of immunotherapies is a story of collaboration says Prof Robyn Ward, but given the time it took, is this really what success looks like?
Read more -
Targeted MND therapy gains fast PBS berth
- Fri Sep 11
Fast-tracked through TGA and PBS, the first therapy for a rare form of ALS is to be funded on the PBS four months after TGA registration.
Read more -
How a failed PBS listing changed the game
- Wed Sep 9
Journalist Natasha Robinson reveals the instigation behind her ‘Medicine Wars’ series as former ministerial advisor Jamie Snashall names the government PBS funding blockers.
Read more -
Confidence dives in Australian innovative pharma
- Wed Sep 9
One in two innovative pharma employees is anticipating job losses, but are things really that bad? On Q’s 2026 Salary & Job Market report reveals all.
Read more